BIO-key International, Inc.
BKYI
$4.55
-$0.09-2.03%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 33.49% | -25.88% | -27.75% | 48.68% | -26.32% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 33.49% | -25.88% | -27.75% | 48.68% | -26.32% |
| Cost of Revenue | 34.63% | 3.43% | -23.03% | 76.97% | -6.71% |
| Gross Profit | 33.25% | -32.29% | -29.05% | 40.24% | -29.44% |
| SG&A Expenses | -4.55% | 1.19% | -12.91% | -13.46% | -23.02% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.46% | 2.37% | -10.40% | -0.52% | -16.44% |
| Operating Income | 75.38% | -34.97% | -53.72% | 34.47% | -25.88% |
| Income Before Tax | 72.17% | -203.57% | -30.55% | 29.97% | -44.33% |
| Income Tax Expenses | -- | 171.74% | -- | -- | -- |
| Earnings from Continuing Operations | 72.17% | -209.80% | -30.55% | 29.97% | -44.33% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 72.17% | -209.80% | -30.55% | 29.97% | -44.33% |
| EBIT | 75.38% | -34.97% | -53.72% | 34.47% | -25.88% |
| EBITDA | 83.97% | -39.53% | -69.71% | 36.71% | -33.28% |
| EPS Basic | 87.35% | -1.08% | 62.54% | 79.99% | 50.42% |
| Normalized Basic EPS | 87.35% | 58.91% | 62.55% | 79.99% | 50.42% |
| EPS Diluted | 87.35% | -1.08% | 62.54% | 79.99% | 50.42% |
| Normalized Diluted EPS | 87.35% | 58.91% | 62.55% | 79.99% | 50.42% |
| Average Basic Shares Outstanding | 120.14% | 206.53% | 248.57% | 250.03% | 191.15% |
| Average Diluted Shares Outstanding | 120.14% | 206.53% | 248.57% | 250.03% | 191.15% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |